Summit Therapeutics (NASDAQ:SMMT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Summit Therapeutics (SMMT) operate in?

Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Summit Therapeutics Stock (NASDAQ: SMMT) stock price, news, charts, stock research, profile.

Open	$18.88
Close	$19.00
Volume / Avg.	760.56K / 2.79M
Day Range	$18.33 - $19.08
52 Wk Range	2.10 - 33.89
Market Cap	$14.01B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	14.17%
Days to Cover	10.62

Recent News

BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential

Goldman Sachs upgrades BioNTech to Buy, highlighting the potential of its cancer drug BNT327 and forecasting strong future revenue amid shifting company focus.

Vandana Singh

MarketBeat Week in Review – 11/4 - 11/8

Markets rallied strongly this week as investors got a clear outcome in the presidential election and an expected interest rate cut by the Federal Reserve. Is this a relief rally, the continuation of a Trump trade, or the

MarketBeat

Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo

JMP Securities initiates coverage on Summit Therapeutics, citing promising data for ivonescimab in NSCLC and setting a $32 price target amid strong trial results.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$18.88
Close	$19.00
Volume / Avg.	760.56K / 2.79M
Day Range	$18.33 - $19.08
52 Wk Range	2.10 - 33.89
Market Cap	$14.01B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	14.17%
Days to Cover	10.62

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Summit Therapeutics (SMMT) stock?

You can purchase shares of Summit Therapeutics (NASDAQ:SMMT) through any online brokerage.

View our list of the best stock brokerages

Who are Summit Therapeutics (SMMT) competitors?

Other companies in Summit Therapeutics’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Summit Therapeutics (SMMT) stock?

Summit Therapeutics has a consensus price target of $33.33.

What is the current price for Summit Therapeutics (SMMT)?

The stock price for Summit Therapeutics (NASDAQ: SMMT) is $19 last updated December 24, 2024 at 2:59 PM EST.

Does Summit Therapeutics (SMMT) pay a dividend?

There are no upcoming dividends for Summit Therapeutics.

When is Summit Therapeutics (NASDAQ:SMMT) reporting earnings?

Summit Therapeutics’s Q4 earnings are confirmed for Tuesday, February 18, 2025.

Is Summit Therapeutics (SMMT) going to split?

There is no upcoming split for Summit Therapeutics.

What sector and industry does Summit Therapeutics (SMMT) operate in?

Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Summit Therapeutics

Summit Therapeutics (SMMT) Forecast